Exploring miRNAs' Based Modeling Approach for Predicting PIRA in Multiple Sclerosis: A Comprehensive Analysis

Area of Science:

• Neuroimmunology
• Biomarker Discovery
• Genomics

Background:

• Multiple sclerosis (MS) pathophysiology involves inflammation and neurodegeneration.
• Disease Modifying Therapies (DMTs) reduce relapses but not all disability progression.
• Progression Independent of Relapse Activity (PIRA) significantly impacts long-term disability.

Purpose of the Study:

• Identify microRNA (miRNA) biomarkers to predict PIRA in relapsing-remitting MS (RRMS).
• Develop models for stratifying patients based on disease trajectory.
• Enhance personalized treatment strategies for early MS stages.

Main Methods:

• Analyzed miRNA profiles from peripheral blood mononuclear cells of 25 RRMS patients before and after high-efficacy DMTs.
• Utilized Agilent microarrays for miRNA profiling.
• Employed multivariate logistic and linear models with randomization tests for analysis.

Main Results:

• Selected a subset of miRNAs correlated with PIRA and Expanded Disability Status Scale (EDSS) changes.
• Developed a robust logistic model predicting PIRA status with high accuracy (AUC = 0.971).
• Built a multilinear model using four miRNA predictors to describe EDSS changes.

Conclusions:

• Multivariate modeling of miRNA expression shows promise for predicting MS disability progression.
• Baseline miRNA profiles can stratify patients regarding PIRA risk.
• These findings support the development of personalized therapeutic approaches for MS.